237 related articles for article (PubMed ID: 12027589)
1. Localisation and activity of cathepsins K and B in equine osteoclasts.
Gray AW; Davies ME; Jeffcott LB
Res Vet Sci; 2002 Apr; 72(2):95-103. PubMed ID: 12027589
[TBL] [Abstract][Full Text] [Related]
2. Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones.
Xia L; Kilb J; Wex H; Li Z; Lipyansky A; Breuil V; Stein L; Palmer JT; Dempster DW; Brömme D
Biol Chem; 1999 Jun; 380(6):679-87. PubMed ID: 10430032
[TBL] [Abstract][Full Text] [Related]
3. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
[TBL] [Abstract][Full Text] [Related]
4. Differential distribution of cathepsins B and L in articular cartilage during skeletal development in the horse.
Gläser KE; Davies ME; Jeffcott LB
Equine Vet J; 2003 Jan; 35(1):42-7. PubMed ID: 12553461
[TBL] [Abstract][Full Text] [Related]
5. Equine osteoclast-like cells generated in vitro demonstrate similar characteristics to directly isolated mature osteoclasts.
Gray AW; Davies ME; Jeffcott LB
Res Vet Sci; 2000 Apr; 68(2):161-7. PubMed ID: 10756134
[TBL] [Abstract][Full Text] [Related]
6. Different cysteine proteinases involved in bone resorption and osteoclast formation.
Brage M; Abrahamson M; Lindström V; Grubb A; Lerner UH
Calcif Tissue Int; 2005 Jun; 76(6):439-47. PubMed ID: 15906014
[TBL] [Abstract][Full Text] [Related]
7. Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption.
Dodds RA; James IE; Rieman D; Ahern R; Hwang SM; Connor JR; Thompson SD; Veber DF; Drake FH; Holmes S; Lark MW; Gowen M
J Bone Miner Res; 2001 Mar; 16(3):478-86. PubMed ID: 11277265
[TBL] [Abstract][Full Text] [Related]
8. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
[TBL] [Abstract][Full Text] [Related]
9. Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis.
Morko JP; Söderström M; Säämänen AM; Salminen HJ; Vuorio EI
Ann Rheum Dis; 2004 Jun; 63(6):649-55. PubMed ID: 15140771
[TBL] [Abstract][Full Text] [Related]
10. Cystatin B as an intracellular modulator of bone resorption.
Laitala-Leinonen T; Rinne R; Saukko P; Väänänen HK; Rinne A
Matrix Biol; 2006 Apr; 25(3):149-57. PubMed ID: 16321512
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
12. Concanavalin A directly stimulates bone-resorbing activity of osteoclasts and their gene expression of cathepsin K/OC-2.
Kakudo S; Mano H; Shiokawa M; Mori Y; Kumegawa M; Hakeda Y
Biochem Biophys Res Commun; 1997 May; 234(3):600-4. PubMed ID: 9175759
[TBL] [Abstract][Full Text] [Related]
13. A cytochemical assay for osteoclast cathepsin K activity.
Dodds RA
Cell Biochem Funct; 2003 Sep; 21(3):231-4. PubMed ID: 12910475
[TBL] [Abstract][Full Text] [Related]
14. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
15. A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys.
Kumar S; Dare L; Vasko-Moser JA; James IE; Blake SM; Rickard DJ; Hwang SM; Tomaszek T; Yamashita DS; Marquis RW; Oh H; Jeong JU; Veber DF; Gowen M; Lark MW; Stroup G
Bone; 2007 Jan; 40(1):122-31. PubMed ID: 16962401
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin K in aseptic hip prosthesis loosening: expression in osteoclasts without polyethylene wear particles.
Hansen T; Otto M; Gaumann A; Eckardt A; Petrow PK; Delank KS; Kirkpatrick CJ; Kriegsmann J
J Rheumatol; 2001 Jul; 28(7):1615-9. PubMed ID: 11469470
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma.
Hansen T; Unger RE; Gaumann A; Hundorf I; Maurer J; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Dec; 14(12):1226-31. PubMed ID: 11743044
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone.
Inaoka T; Bilbe G; Ishibashi O; Tezuka K; Kumegawa M; Kokubo T
Biochem Biophys Res Commun; 1995 Jan; 206(1):89-96. PubMed ID: 7818555
[TBL] [Abstract][Full Text] [Related]
19. Effects of antisense mediated inhibition of cathepsin K on human osteoclasts obtained from peripheral blood.
Avnet S; Lamolinara A; Zini N; Solimando L; Quacquaruccio G; Granchi D; Maraldi NM; Giunti A; Baldini N
J Orthop Res; 2006 Aug; 24(8):1699-708. PubMed ID: 16795033
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of cathepsin D, K, and L in the process of endochondral ossification in the human.
Nakase T; Kaneko M; Tomita T; Myoui A; Ariga K; Sugamoto K; Uchiyama Y; Ochi T; Yoshikawa H
Histochem Cell Biol; 2000 Jul; 114(1):21-7. PubMed ID: 10959819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
